Indraprastha Medical [INDRAMEDCO] vs Dr. Agarwal's Eye [DRAGARWQ] Detailed Stock Comparison

Indraprastha Medical

Dr. Agarwal's Eye
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Indraprastha Medical wins in 13 metrics, Dr. Agarwal's Eye wins in 7 metrics, with 0 ties. Indraprastha Medical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Indraprastha Medical | Dr. Agarwal's Eye | Better |
---|---|---|---|
P/E Ratio (TTM) | 24.13 | 40.35 | Indraprastha Medical |
Price-to-Book Ratio | 7.00 | 11.14 | Indraprastha Medical |
Debt-to-Equity Ratio | 5.49 | 158.94 | Indraprastha Medical |
PEG Ratio | 1.61 | 1.81 | Indraprastha Medical |
EV/EBITDA | 15.36 | 20.32 | Indraprastha Medical |
Profit Margin (TTM) | 12.21% | 13.96% | Dr. Agarwal's Eye |
Operating Margin (TTM) | 17.25% | 22.71% | Dr. Agarwal's Eye |
EBITDA Margin (TTM) | 17.25% | 22.71% | Dr. Agarwal's Eye |
Return on Equity | 26.98% | 26.07% | Indraprastha Medical |
Return on Assets (TTM) | 18.90% | 8.91% | Indraprastha Medical |
Free Cash Flow (TTM) | $1.20B | $-83.80M | Indraprastha Medical |
Dividend Yield | 0.95% | 0.11% | Indraprastha Medical |
1-Year Return | 9.20% | 4.92% | Indraprastha Medical |
Price-to-Sales Ratio (TTM) | 3.04 | 5.64 | Indraprastha Medical |
Enterprise Value | $38.89B | $26.43B | Indraprastha Medical |
EV/Revenue Ratio | 2.83 | 6.38 | Indraprastha Medical |
Gross Profit Margin (TTM) | 38.19% | 77.64% | Dr. Agarwal's Eye |
Revenue per Share (TTM) | $150 | $881 | Dr. Agarwal's Eye |
Earnings per Share (Diluted) | $18.86 | $123.07 | Dr. Agarwal's Eye |
Beta (Stock Volatility) | 0.57 | -0.36 | Dr. Agarwal's Eye |
Indraprastha Medical vs Dr. Agarwal's Eye Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Indraprastha Medical | 1.51% | 3.48% | -3.24% | -7.50% | 14.75% | -14.65% |
Dr. Agarwal's Eye | -0.31% | 2.98% | 9.84% | 14.47% | 16.54% | -23.53% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Indraprastha Medical | 9.20% | 642.22% | 819.28% | 590.66% | 890.15% | 874.50% |
Dr. Agarwal's Eye | 4.92% | 358.10% | 1,895.43% | 3,647.65% | 6,296.19% | 14,656.04% |
News Based Sentiment: Indraprastha Medical vs Dr. Agarwal's Eye
Indraprastha Medical
News based Sentiment: MIXED
September presented a mixed bag for Indraprastha Medical, with slightly disappointing Q2 results countered by a consistent dividend and an attractive valuation. While profitability declined, the company maintains a commitment to shareholder returns and appears undervalued compared to its peers, creating a complex investment picture.
Dr. Agarwal's Eye
News based Sentiment: POSITIVE
September was a strong month for Dr. Agarwal's, marked by impressive financial results, a commitment to shareholder returns through a 35% dividend, and increasing institutional investor confidence. Long-term projections from Walletinvestor.com further reinforce a positive investment outlook, suggesting significant potential for future growth.
Performance & Financial Health Analysis: Indraprastha Medical vs Dr. Agarwal's Eye
Metric | INDRAMEDCO | DRAGARWQ |
---|---|---|
Market Information | ||
Market Cap | ₹42.43B | ₹23.46B |
Market Cap Category | Small cap | Small cap |
10 Day Avg. Volume | 115,470 | 1,476 |
90 Day Avg. Volume | 212,862 | 3,361 |
Last Close | ₹462.40 | ₹4,950.65 |
52 Week Range | ₹307.25 - ₹572.00 | ₹3,500.00 - ₹7,300.00 |
% from 52W High | -19.16% | -32.18% |
All-Time High | ₹572.00 (Jan 06, 2025) | ₹7,300.00 (Dec 30, 2024) |
% from All-Time High | -19.16% | -32.18% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.05% | 0.17% |
Quarterly Earnings Growth | 0.15% | 0.22% |
Financial Health | ||
Profit Margin (TTM) | 0.12% | 0.14% |
Operating Margin (TTM) | 0.17% | 0.23% |
Return on Equity (TTM) | 0.27% | 0.26% |
Debt to Equity (MRQ) | 5.49 | 158.94 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹65.04 | ₹445.96 |
Cash per Share (MRQ) | ₹35.08 | ₹52.76 |
Operating Cash Flow (TTM) | ₹1.78B | ₹738.70M |
Levered Free Cash Flow (TTM) | ₹1.61B | ₹546.50M |
Dividends | ||
Last 12-Month Dividend Yield | 0.95% | 0.11% |
Last 12-Month Dividend | ₹4.50 | ₹5.00 |
Valuation & Enterprise Metrics Analysis: Indraprastha Medical vs Dr. Agarwal's Eye
Metric | INDRAMEDCO | DRAGARWQ |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 24.13 | 40.35 |
Forward P/E | 182.00 | 510.88 |
PEG Ratio | 1.61 | 1.81 |
Price to Sales (TTM) | 3.04 | 5.64 |
Price to Book (MRQ) | 7.00 | 11.14 |
Market Capitalization | ||
Market Capitalization | ₹42.43B | ₹23.46B |
Enterprise Value | ₹38.89B | ₹26.43B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 2.83 | 6.38 |
Enterprise to EBITDA | 15.36 | 20.32 |
Risk & Other Metrics | ||
Beta | 0.57 | -0.36 |
Book Value per Share (MRQ) | ₹65.04 | ₹445.96 |
Financial Statements Comparison: Indraprastha Medical vs Dr. Agarwal's Eye
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | INDRAMEDCO | DRAGARWQ |
---|---|---|
Revenue/Sales | ₹3.65B | ₹1.17B |
Cost of Goods Sold | ₹2.26B | ₹261.40M |
Gross Profit | ₹1.39B | ₹907.80M |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹629.70M | ₹265.50M |
EBITDA | ₹800.50M | ₹379.30M |
Pre-Tax Income | ₹683.10M | ₹231.90M |
Income Tax | ₹168.50M | ₹59.30M |
Net Income (Profit) | ₹514.60M | ₹172.60M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | INDRAMEDCO | DRAGARWQ |
---|---|---|
Cash & Equivalents | ₹614.80M | ₹111.60M |
Total Current Assets | ₹4.31B | ₹559.40M |
Total Current Liabilities | ₹1.79B | ₹869.80M |
Long-Term Debt | ₹305.40M | ₹3.06B |
Total Shareholders Equity | ₹5.97B | ₹2.10B |
Retained Earnings | ₹4.75B | ₹1.99B |
Property, Plant & Equipment | ₹2.60B | ₹1.37B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | INDRAMEDCO | DRAGARWQ |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | INDRAMEDCO | DRAGARWQ |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 115,470 | 1,476 |
Average Daily Volume (90 Day) | 212,862 | 3,361 |
Shares Outstanding | 91.67M | 4.70M |
Float Shares | 41.01M | 1.11M |
% Held by Insiders | 0.58% | 0.81% |
% Held by Institutions | 0.03% | 0.02% |
Dividend Analysis & Yield Comparison: Indraprastha Medical vs Dr. Agarwal's Eye
Metric | INDRAMEDCO | DRAGARWQ |
---|---|---|
Last 12-Month Dividend | ₹4.50 | ₹5.00 |
Last 12-Month Dividend Yield | 0.95% | 0.11% |
3-Year Avg Annual Dividend | ₹4.00 | ₹4.50 |
3-Year Avg Dividend Yield | 1.26% | 0.12% |
3-Year Total Dividends | ₹12.00 | ₹13.50 |
Ex-Dividend Date | Sep 18, 2025 | Nov 08, 2024 |